Artwork

Indhold leveret af IMPACT Medicom. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af IMPACT Medicom eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyperglycemia

29:52
 
Del
 

Manage episode 366525778 series 2812899
Indhold leveret af IMPACT Medicom. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af IMPACT Medicom eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Welcome to our podcast series discussing treatment-related adverse events with enfortumab vedotin in the management of urothelial carcinoma. In this fourth episode, we discuss the management of hyperglycemia associated with enfortumab vedotin, or EV.
Our Guests:
This fourth episode on the management of neuropathy is hosted by Dr Nimira Alimohamed, Medical Oncologist at the Tom Baker Cancer Centre, Calgary, AB and Clinical Assistant Professor in the Department of Medicine at the University of Calgary.
In this episode, Dr Alimohamed interviews Dr. Minna Woo, Professor in the Departments of Medicine, Institute of Medical Science, Immunology, and Pharmacology and Toxicology at the University of Toronto and Director of the Banting & Best Diabetes Centre.
This podcast episode was sponsored by Seagen Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com.

  continue reading

67 episoder

Artwork
iconDel
 
Manage episode 366525778 series 2812899
Indhold leveret af IMPACT Medicom. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af IMPACT Medicom eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Welcome to our podcast series discussing treatment-related adverse events with enfortumab vedotin in the management of urothelial carcinoma. In this fourth episode, we discuss the management of hyperglycemia associated with enfortumab vedotin, or EV.
Our Guests:
This fourth episode on the management of neuropathy is hosted by Dr Nimira Alimohamed, Medical Oncologist at the Tom Baker Cancer Centre, Calgary, AB and Clinical Assistant Professor in the Department of Medicine at the University of Calgary.
In this episode, Dr Alimohamed interviews Dr. Minna Woo, Professor in the Departments of Medicine, Institute of Medical Science, Immunology, and Pharmacology and Toxicology at the University of Toronto and Director of the Banting & Best Diabetes Centre.
This podcast episode was sponsored by Seagen Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com.

  continue reading

67 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning